Skip to main content
. 2021 Nov 30;13:325–332. doi: 10.2147/OARRR.S339134

Table 5.

Shows the Distribution of Disease-Modifying Antirheumatic Drugs (DMARDs) Among the Study Participants According to RA Serotypes

SPRA (37) SNRA (23) Total
NO % NO %
DMARDs Prednisolone 32 86.5% 20 87% 52
HCQ 28 75.7% 21 91.3% 49
Methotrexate 20 54.1% 6 26.1% 26